Skip to main content
Top
Published in:

03-01-2024 | Thyroid Cancer | Original Research

TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort

Authors: Sergio D. Cruz-Romero, Sebastián González, José Y. Juez, David S. Becerra, Ana M. Baldión, José A. Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A. Rodríguez-Urrego

Published in: Advances in Therapy | Issue 2/2024

Login to get access

Abstract

Introduction

In Colombia, thyroid cancer ranks among the highest incidences, yet our population lacks studies on its molecular profile. This study aims to characterize clinical, histopathologic and molecular data in a Colombian cohort with papillary thyroid carcinoma (PTC).

Methods

A retrospective review of clinical history, clinicopathologic characteristics, treatment and 5–10-year follow-up for all patients was done. DNA and RNA were extracted from formalin-fixed paraffin-embedded (FFPE) tissue using the Quick-DNA & RNA FFPE Min iPrep kit (Zymo Research). Next-generation sequencing (NGS) analysis was performed with SOPHiA Solid Tumor Solutions kit (SOPHiA GENETICS). Tumor mutation genomic analysis used SOPHiA DDM™ platform, with descriptive analysis reporting frequencies, means and associations via chi-square analysis.

Results

Among 231 sequenced patients, mean age at diagnosis was 46 (± 12.35) years, with higher frequency in women (81.82%). Two cases were reclassified as non-invasive follicular thyroid neoplasm (NIFT-P); an NRAS mutation was found in one of them. Predominant histologic subtype was classic PTC (57.64%) followed by tall cell (28.82%). Of the 229 sequenced carcinomas, mutations were identified in 186 cases, including BRAF, IDH1, RAS and PIK3CA. Notable copy number variations (CNVs) were PDGFRA, CDK4 and KIT, with RET being the most frequent gene fusion, including CCDC6-RET in two classic subtype cases.

Conclusion

This is the first study in Colombia (TIROSEC) to our knowledge that integrates molecular and histopathologic profiles enriching our local comprehension and knowledge of PTC. The identification of target mutations such as BRAF, RET and NTRK fusions holds the potential to guide targeted therapies for tumor recurrence and predict aggressive behavior.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Global Burden of Disease Cancer Collaboration, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553. https://doi.org/10.1001/jamaoncol.2018.2706.CrossRefPubMed Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Global Burden of Disease Cancer Collaboration, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553. https://​doi.​org/​10.​1001/​jamaoncol.​2018.​2706.CrossRefPubMed
6.
go back to reference Marin LF, Torres JL, Wandurraga EA, Aristizabal C, Aristizabal N, Sylva DI, et al. Predictores de recaída en carcinoma diferenciado de tiroides en Colombia: estudio multicéntrico. Revista Colombiana de Endocrinol Diabetes Metab. 2019;6:92–100.CrossRef Marin LF, Torres JL, Wandurraga EA, Aristizabal C, Aristizabal N, Sylva DI, et al. Predictores de recaída en carcinoma diferenciado de tiroides en Colombia: estudio multicéntrico. Revista Colombiana de Endocrinol Diabetes Metab. 2019;6:92–100.CrossRef
10.
go back to reference Morganti S, Tarantino P, Ferraro E, D’Amico P, Duso BA, Curigliano G. Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in cancer. In: Ruiz-Garcia E, de La Astudillo Vega H, editors. Translational research and onco-omics applications in the era of cancer personal genomics, vol. 1168. Cham: Springer International Publishing; 2019. p. 9–30. https://doi.org/10.1007/978-3-030-24100-1_2.CrossRef Morganti S, Tarantino P, Ferraro E, D’Amico P, Duso BA, Curigliano G. Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in cancer. In: Ruiz-Garcia E, de La Astudillo Vega H, editors. Translational research and onco-omics applications in the era of cancer personal genomics, vol. 1168. Cham: Springer International Publishing; 2019. p. 9–30. https://​doi.​org/​10.​1007/​978-3-030-24100-1_​2.CrossRef
16.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed
19.
go back to reference Romero-Rojas A, Cuervo-Martínez J, Osorio-Arango K, Olaya N. Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerología, 2006–2012. Biomedica. 2015;35:429–36.PubMed Romero-Rojas A, Cuervo-Martínez J, Osorio-Arango K, Olaya N. Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerología, 2006–2012. Biomedica. 2015;35:429–36.PubMed
30.
go back to reference Almukhtar ZK. Histopathological types of papillary thyroid carcinoma: clinicopathologic study. Open Access Maced J Med Sci. 2022;10(A):79–83. Almukhtar ZK. Histopathological types of papillary thyroid carcinoma: clinicopathologic study. Open Access Maced J Med Sci. 2022;10(A):79–83.
38.
go back to reference Han F, Zhang L, Zhang S, Zhou H, Yi X. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K. Int J Clin Exp Pathol. 2015;8:5896–901.PubMedPubMedCentral Han F, Zhang L, Zhang S, Zhou H, Yi X. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K. Int J Clin Exp Pathol. 2015;8:5896–901.PubMedPubMedCentral
Metadata
Title
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort
Authors
Sergio D. Cruz-Romero
Sebastián González
José Y. Juez
David S. Becerra
Ana M. Baldión
José A. Hakim
Deyanira González-Devia
Sandra Perdomo
Paula A. Rodríguez-Urrego
Publication date
03-01-2024
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 2/2024
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-023-02756-y

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more